Studya
Designb
Targeted brain regionc
Subjectsd
Limitations
PET
Oquendo et al. (2003)
PET:
Whole brain
25 patients (M + F) meeting DSM-III-R criteria of a major depressive episode and who have attempted suicide: 16 patients had a history of high-lethality suicide attempts (mean 42.9 years), 9 patients had a history of lo-lethality suicide attempts (mean 30.4 years)
Small sample size; direct brain injuries not ruled out
Regional brain serotonergic function
Leyton et al. (2006)
PET:
PFC
26 subjects (M + F): 10 patients have attempted suicide (mean 37.7 years) and 16 healthy subject (mean 35.5 years)
Effects of drugs on 5-HT transmission; small sample size; imaging technique possibly not the best to assess 5-HT neurotransmission
α[11C]MTrp trapping
SPECT
Audenaert et al. (2001)
SPET:
Frontal cortex
21 subjects, mean 30.4 years (M + F): 9 patients who have attempted suicide and 12 healthy subjects
Impact of alcohol and medication on clearance of the ligand; possible effect of physical trauma on binding index
Serotonin-2A receptor functioning
Audenaert et al. (2002)*
SPECT:
Whole brain
40 subjects (M + F): 20 depressed patients who recently (< 7 days) attempted suicide (19–49 years) and 20 healthy subjects (18–50)
Influence of medication; selection bias; at random division of subgroups
Binding potential
PFC
van Heeringen et al. (2003)
SPECT:
PFC
21 subjects (M + F): 9 patients who have attempted suicide (mean 32.4 years) and 12 healthy subjects (mean 28.9 years)
Small sample size; composition of patient sample; effects of alcohol and medication; possible effect of physical trauma on binding index
Serotonin-2A receptor functioning
Lindström et al. (2004)
SPECT:
Whole brain
24 subjects, mean 38.8 years (M + F): 12 patients who attempted suicide (5 violent and 7 non violent) and 12 healthy matched subjects
Possible type 2 error
Brain serotonin and dopamine transporters
Ryding et al. (2006)
SPECT:
Whole brain
24 subjects (M + F): 12 patients who attempted suicide (mean 38.8 years) and 12 matched healthy subjects
Serotonin transporter and dopamine transporter
Amen et al. (2009)
SPECT:
Whole brain
36 subjects (M + F): 12 patients meeting DSM-IV criteria for depression who committed suicide since the brain imaging (mean 33.8 years), 12 patients meeting DSM-IV criteria for depression who did not commit suicide and 12 healthy subjects
Heterogeneous sample; medication; lack of data for all subjects
In vivo brain differences
PFC
Subgenual cingulate
Willeumier et al. (2011)
SPECT:
Whole brain
84 subjects (M + F): 21 patients meeting DSM-IV criteria for depression who committed suicide since the brain imaging (mean 36 years), 36 matched non-suicidal depressed subjects (mean 36 years) and 27 matched healthy subjects (mean 35 years)
Follow-up study of Amen et al. (2009), with only 9 additional patients who committed suicide
Technetium-99 m hexamethylpropylene amine oxime brain uptake
van Heeringen et al. (2010)
SPECT:
Whole brain
39 subjects (M + F): 39 admitted patients, treated for a depressive episode according to DSM-IV-TR criteria, subdivided in 3 groups according to level of mental pain
Impact of medication
Regional cerebral blood flow under resting conditions
6.3.1 PET Studies
Oquendo and colleagues published an interesting study in 2003, in which they investigated the brains of 16 high-lethality and 9 low-lethality suicide attempters having a depressive episode. The patients were scanned in resting condition with 18F-FDG PET imaging in order to estimate regional brain activity in conditions where external activation is minimized or standardized. Subjects were scanned after a single-blind placebo and after fenfluramine hydrochloride administration on a second day. Fenfluramine is a serotonin agonist that provokes an increase in the presynaptic release of serotonin. Secondary and proportional to this postsynaptic receptor stimulation, the anterior pituitary gland releases prolactin in the circulation. If the serotonergic system is impaired, a blunted increase in prolactin is found (Malone et al. 1996; Correa et al. 2000). Besides an increase in prolactin, fenfluramine also increases frontal cortex metabolism (Soloff et al. 2003). The authors found that depressed high-lethality suicide attempters showed relative hypometabolism compared to low-lethality attempters in the ventral, medial, and lateral prefrontal cortex. This difference was more pronounced after fenfluramine administration. Lethality of the attempt appeared to be inversely correlated with metabolism in the ventromedial prefrontal cortex after challenge with fenfluramine. A lower mean regional cerebral metabolic rate of glucose uptake (rCMRglu) correlated with higher lethality of suicidal behavior. The authors also demonstrated that higher verbal fluency correlated positively with rCMRglu in the same regions of the prefrontal cortex and that lethality of the suicide attempt inversely correlated with prolactin after challenge. They found a lower CMRglu in high- versus low-lethality suicide attempters. This hypometabolism in frontal cortex structures was related to the degree of suicide intent and impulsivity and not to depression (Oquendo et al. 2003).
Leyton and coworkers (2006) measured regional serotonin synthesis in the brain with PET and α-(11C)-methyl-L-tryptophan trapping in ten patients who had made a high-lethality suicide attempt and in 16 healthy controls. Suicide attempters showed reduced serotonin synthesis in the orbital and ventromedial prefrontal cortices. α-(11C)-methyl-L-tryptophan trapping in these regions correlated negatively with suicide intent. Elevated α-(11C)-methyl-L-tryptophan trapping was seen in the left thalamus, right paracentral lobule, and the left middle occipital cortex. The investigators concluded that low serotonin synthesis in the prefrontal cortex might lower the threshold for suicidal behavior.
6.3.2 SPECT Studies
A few studies used SPECT imaging to study functional changes in brain functions. Audenaert and coworkers (2001) studied nine patients who had recently (1–7 days) attempted suicide and compared these to 12 age-matched healthy controls using 123I-5-I-R91150 SPECT. They found a significantly reduced binding index in the frontal cortex in the patient group. The binding index was significantly lower in the deliberate self-injury patients compared to the deliberate self-poisoning subjects. The results indicate a decrease in the number and/or in the binding affinity of 5-HT2A receptors. Further analysis revealed a significant negative correlation between 5-HT2A-receptor binding and levels of hopelessness, a very important clinical predictor of suicidal behavior (van Heeringen et al. 2003).
In a split-dose 99mTc-ECD SPECT activation paradigm, Audenaert and colleagues (2001) included 20 depressed patients who had recently attempted suicide and compared them to 20 healthy volunteers. The neuropsychological activation consisted of a verbal fluency test. When compared to healthy volunteers, patients showed a blunted increase in perfusion in the prefrontal cortex during specific verbal fluency tasks. When comparing the activated brain regions between healthy volunteers and patients in the category fluency paradigm, a statistically significant blunting of the perfusion was observed in the patient group in the left gyrus frontalis inferior, right gyrus parietalis inferior, and bilateral gyrus cinguli anterior. There were no regions with significantly increased perfusion in the patient group compared to the controls. When comparing the activated brain regions between healthy and depressed subjects in the letter fluency paradigm, the authors found a statistically significant blunting of the perfusion in the depressed group in the left and right gyrus temporalis medius, right gyrus cinguli anterior, and hypothalamic region. There were no regions with significantly increased perfusion in the patient group compared to control subjects. The authors suggest that the blunted increase in prefrontal blood perfusion might be a biological reason for reduced drive and loss of initiative in attempted suicide patients.

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

